ITPP Myo-Inositol

ITTP, also known as Myo-inositol trispyrophospate, is a research compound currently under investigation for its potential to assist patients who have suffered from myocardial infarctions, commonly known as heart attacks. This is despite ITTP being first used for racehorses.

Research studies for ITTP are primarily focused on its ability to enhance the oxygen supply to weakened or damaged cardiac muscle, which can greatly aid in the recovery process.

One of the key advantages of ITPP is its capacity to stimulate hemoglobin, a molecule responsible for carrying oxygen in the blood, to release oxygen at levels beyond the normal range. In experimental studies conducted on mice, the administration of ITPP dissolved in water resulted in a 35% increase in exercise capacity. Moreover, when delivered through using intramuscular injection, the potential rise in exercise levels reached 60%.

ITTP is not an FDA-approved drug. Thus, buy ITPP injection online myo inositol for research studies only.

ITPP Myo-Inositol Product Details

ITPP, also known as Myo Inositol Trispyrophosphate, is a synthetic substance derived from a chemical called Myo Inositol Hexakisphosphate, which has antioxidant and anti-cancer properties. It is usually produced in mammalian cells in the laboratory.

In research settings, ITPP can be administered orally or through intravenous injections. However, it’s important to note that ITPP is currently being investigated and is not recommended for human consumption. Its purchase should strictly be for research purposes only.

ITPP is often associated with improving performance in racehorses, but it is not approved by the FDA for such use. In fact, most professional sports, including horse racing, prohibit the use of Myo Inositol Trispyrophosphate (ITPP).

  • CAS Number 623552-11-4
  • Molar Mass 605.984 g·mol−1
  • Chemical Formula C6H12O21P6
  • IUPAC Name 4,6,11,13,18,20-hexahydroxy-3,5,7,10,12,14,17,19,21- nonaoxa-4λ5,6λ5,11λ5,13λ5,18λ5,20λ hexaphosphatetracyclo[14.5.0.02,8.09,15]henicosane 4,6,11,13,18,20-hexaoxide

Key Features of ITPP Myo-Inositol for Sale

  • 98% Purity
  • 1000mg

Potential Benefits of ITPP Myo-Inositol

ITPP and Cancer

Hypoxia, characterized by low oxygen levels, stimulates angiogenesis, and the formation of new blood vessels. This process can accelerate tumor growth and facilitate the spread of cancer cells to other organs. [R]

ITPP, as a synthetic allosteric effector, has shown potential anti-cancer effects by reducing hypoxia and angiogenesis, as observed in various animal and cell experiments. By diminishing hypoxia and inhibiting angiogenesis, ITPP may reduce the likelihood of tumor growth and metastasis.

Research suggests that these effects of ITPP can contribute to preventing the spread of cancer cells and inhibiting tumor growth. Continued investigations are necessary further to understand the potential applications of ITPP in cancer treatment. [R] [R]

ITPP and Exercise Capacity

One notable investigation conducted by Professor Jean-Marie Lehn from the University of Strasbourg in France explored the effects of ITPP on exercise capacity. [R]

Mice with heart damage were given ITPP dissolved in water to consume. The results showed a remarkable 35% increase in their exercise ability. Even more impressive was the finding that when ITPP was administered through slow intravenous injection into the mice’s abdomen, their energy levels increased by 60%.

These findings suggest that ITPP dosage can enhance maximal exercise capacity in mammals. Other studies conducted on mice have also indicated that oral or intramuscular administration of ITPP may improve exercise performance. [R]

ITPP and Hypoxia

Researchers are currently studying the potential of ITPP injections to alleviate hypoxia, a condition where tissues receive inadequate oxygen supply. ITPP has shown promise in regulating the release of oxygen by red blood cells. [R]

Hypoxia triggers angiogenesis, the formation of new blood vessels, as a natural response to increase oxygen delivery to deprived tissues. Studies have indicated that ITPP may reduce the presence of hypoxia indicators such as VEGF and hypoxia-inducible factor 1alpha. In fact, ITPP has demonstrated the ability to inhibit angiogenesis, potentially reducing the formation of new blood vessels. [R]

In one study, ITPP was found to decrease the binding capacity of red blood cells to oxygen while simultaneously enhancing oxygen transport to tissues. This suggests that ITPP may improve oxygen delivery to hypoxic tissues. [R]

How It Works

ITPP, an allosteric effector of hemoglobin, plays a crucial role in making more oxygen available to tissues. Rather than directly delivering oxygen, ITPP enhances the capacity of red blood cells to transport oxygen to tissues.

In addition to its effect on oxygen transport, ITPP is classified as an inositol phosphate, which is involved in various cellular functions and signaling processes.

ITPP functions by binding to the membrane of red blood cells, specifically hemoglobin, leading to the subsequent release of oxygen. This unique characteristic establishes ITPP as an allosteric effector of hemoglobin.

Furthermore, research suggests that increased oxygen delivery facilitated by ITPP can lead to improved muscle function and activity. Animal studies have also demonstrated potential anti-cancer properties of ITPP, although no human studies have been conducted in this regard.

Precautions

Individuals who are considering the use of ITPP Myo Inositol Trispyrophosphate should be aware of certain precautions. It is important to note that the use of ITPP increases oxygen delivery to tissues and may result in increased energy levels. However, certain groups of people should avoid using ITPP.

Pregnant or breastfeeding individuals: Due to limited research on the safety of ITPP Myo Inositol Trispyrophosphate during pregnancy and lactation, it is advisable for pregnant or breastfeeding individuals to avoid its use or seek medical advice.

Individuals with underlying health conditions: Test subjects with pre-existing medical conditions, such as cardiovascular diseases, diabetes, kidney problems, or liver disorders, should exercise caution and consult with a healthcare professional before using ITPP.

Individuals taking medication: There is a possibility of drug interactions that may affect the safety and efficacy of both ITPP and the medications one is taking.

Children: The safety and appropriate use of ITPP Myo Inositol Trispyrophosphate in children have not been extensively studied. Therefore, its use in children should be approached with caution and under the guidance of a healthcare professional.

Potential Side Effects

As of September 2021, there is limited clinical research specifically on the safety profile of ITPP in humans. However, studies conducted on animals have not reported any significant adverse effects. It is important to note that any substance, including ITPP, may have the potential for side effects or interactions with other medications.

Conclusion

In conclusion, the use of ITPP Myo Inositol offers several potential benefits. Its regulated oxygen-releasing capacity, especially when administered through injections, can enhance the oxygen supply to hypoxic tissues and improve exercise capacity. Studies have shown that ITPP injections, including intramuscular administration, have the potential to increase maximal exercise capacity, leading to maximum results in physical performance.

While ITPP is commonly associated with improving performance in racehorses, its effects on humans are still being researched. Nevertheless, its ability to enhance oxygen delivery to tissues holds promise for improving exercise performance and supporting recovery in various contexts.

Further research is necessary to fully understand and unlock the potential benefits of ITPP Myo Inositol in human health and performance.

Disclaimer: 

Please take note of the scientific applications of this product and carefully read our Terms and Conditions before making a purchase from rcd.bio. By completing your order and submitting payment, you agree to abide by our Terms and Conditions. Please be aware that the product packaging may differ slightly from the images displayed on our website.

If for any reason you are not completely satisfied with the product you receive, please contact us at [email protected]. Our team is dedicated to ensuring customer satisfaction and will be happy to assist you.

PLEASE NOTE: All products offered by rcd.bio are strictly intended for laboratory and research purposes only. They are not intended for use on animals or humans.